Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Stomach Neoplasms 1Small Cell Lung Carcinoma 1Refractory or Relapsed Solid Tumors 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Leukemia 1Lethal Congenital Contracture Syndrome 2 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Barrett Esophagus 1Advanced Breast Cancer 1Adenocarcinoma Of Esophagus 1

Interventions

Cytarabine 16Methotrexate 13Specimen Handling 12venetoclax 11Cyclophosphamide 11fludarabine 8Whole-Body Irradiation 8Biopsy 8merphos 7fludarabine phosphate 7calaspargase pegol 7Vincristine 7Hydrocortisone 7blinatumomab 6Granulocyte Colony-Stimulating Factor 6Dexamethasone 6revumenib 5Mycophenolic Acid 5Leucovorin 5Filgrastim 5Daunorubicin 5Calcium Dobesilate 5Asparaginase 5prednylidene 4dexamethasone acetate 4dexamethasone 21-phosphate 4deltacortene 4Thioguanine 4Tacrolimus 4Stem Cell Transplantation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Biphenotypic, Acute × Itraconazole × 90 days × Clear all
NCT04067336 2026-05-13

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Kura Oncology, Inc.

Phase 1/2 Active not recruiting
263 enrolled 1 FDA
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡